Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia

ClinicalTrials.gov ID: NCT01939548

Public ClinicalTrials.gov record NCT01939548. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-week , Randomized, Phase 2, Double-blind, Parallel-group Study Of Two Dose Levels Of Pf-02545920 Compared To Placebo In The Adjunctive Treatment Of Outpatients With Sub-optimally Controlled Symptoms Of Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study aims to evaluate whether PF-02545920 is safe and effective in the treatment of sub-optimally controlled symptoms of schizophrenia during a 12-week outpatient treatment period. The study will use the Positive and Negative Syndrome Scale (PANSS) to measure change in symptoms for PF-02545920 from baseline compared to placebo.

Study identification

NCT ID
NCT01939548
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
240 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2013 (Type not available)
Primary completion
Oct 2014 (Actual)
Completion
Oct 2014 (Actual)
Last update posted
Aug 22, 2016

2013 – 2014

United States locations

U.S. sites
44
U.S. states
18
U.S. cities
38
Facility City State ZIP Site status
Birmingham Psychiatry Pharmaceutical Studies, Inc. Birmingham Alabama 35226 —
Woodland International Research Group, INC Little Rock Arkansas 72211 —
Comprehensive Clinical Development, Inc. Cerritos California 90703 —
ProScience Research Group Culver City California 90230 —
Synergy Clinical Research of Escondido Escondido California 92025 —
Collaborative Neuroscience Network, Inc. Garden Grove California 92845 —
Pacific Research Partners Oakland California 94612 —
Excell Research, Inc. Oceanside California 92056 —
Neuropsychiatric Research Center of Orange County Orange California 92868 —
CiTrials Riverside California 92506 —
CNRI-San Diego, LLC San Diego California 92102 —
Sharp Mesa Vista Hospital San Diego California 92123 —
Collaborative Neuroscience Network, Inc. Torrance California 90502 —
Bliss Basement Pharmacy Hartford Connecticut 06102 —
Institute of Living Hartford Connecticut 06106 —
Yale University New Haven Connecticut 06519 —
Comprehensive Clinical Development Washington D.C. District of Columbia 20016 —
Florida Clinical Research Center, LLC Bradenton Florida 34208 —
Florida Clinical research Center, LLC Brandenton Florida 34201 —
Innovative Clinical Research, Inc. Lauderhill Florida 33319 —
Medical Research Group of Central Florida Sanford Florida 32771 —
Comprehensive Clinical Development, Inc. Atlanta Georgia 30328 —
Alexian Brothers Center for Psychiatric Research Hoffman Estates Illinois 60169 —
Chinmay K. Patel, DO Hoffman Estates Illinois 60169 —
Behavioral Health Care Associates Schaumburg Illinois 60194 —
Lake Charles Clinical Trials Lake Charles Louisiana 70629 —
Louisiana Clinical Research Shreveport Louisiana 71101 —
CBH Health, LLC Rockville Maryland 20850 —
Psychiatric Care & Research Center O'Fallon Missouri 63368 —
St. Louis Clinical Trials/The Summit@Creve Coeur St Louis Missouri 63141 —
Altea Research Las Vegas Nevada 89102 —
Comprehensive Clinical Development Jamaica New York 11432 —
Manhattan Psychiatric Center's 125th St. Clinic New York New York 10027 —
Manhattan Psychiatric Center Ward's Island New York 10035 —
Midwest Clinical Research Center, LLC Dayton Ohio 45417 —
Cutting Edge Research Group Oklahoma City Oklahoma 73116 —
Research Strategies of Memphis, LLC Memphis Tennessee 38119 —
FutureSearch Trials Austin Texas 78731 —
Community Clinical Research, Inc Austin Texas 78754 —
Futuresearch Trials of Dallas Dallas Texas 75231 —
Pillar Clinical Research LLC Dallas Texas 75243 —
InSite Clinical Research DeSoto Texas 75115 —
Psychiatric and Behaviorial Solutions Salt Lake City Utah 84105 —
Lifetree Clinical Research Salt Lake City Utah 84106 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01939548, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 22, 2016 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01939548 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →